ALL KEYWORDSMetastatic Colorectal CancerRelated SpecialistsShowing 3 of 53Joanna GibsonMD, PhDJill LacyMDMichael CecchiniMDMore Related SpecialistsRelated Clinical TrialsShowing 2 of 5A Randomized, Open-label Phase 3 Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal CancerColorectal CancerColon Adjuvant Chemotherapy Based on Evaluation of Residual DiseaseColorectal CancerMore Related Clinical Trials
